1. South Korea Stocks

  2. •

    Distribution services

  3. •

    Medical distributors
Metacare Co., Ltd.

Metacare Co., Ltd.

KKRX:118000
1,349.00
KRW
+55.00
(+4.25%)
-105.83EPS
20.66BMarket Cap
Metacare Co., Ltd.
KRX:118000
(Korea Stock Exchange)

Recent

price

1,349.00

P/E

ratio

- -

div

yld

- -

ROIC.AI

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
KRW
44,522.47
49,311.18
19,025.67
102,662.28
9,773.24
9,141.62
4,193.75
15,745.89
13,022.12
20,237.55
1,404.97
2,861.77
2,277.71
1,637.83
1,355.67
1,976.27
2,297.76
Revenue per Share
-4,145.79
-17,965.38
-5,461.91
-37,575.28
-7,350.55
-6,062.41
-4,349.31
-1,287.04
-4,668.85
-1,730.85
2,387.68
1,190
-5,910
-1,380
570
30
-91.71
Basic EPS, GAAP
-57,356.93
-562.23
1,110
-1,161.5
-5,138.03
-4,017.39
-2,518.29
-5,657.14
-1,120.85
426.41
770.68
-233.94
-321.44
-1,698.17
105.86
-296.24
192.96
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
33,512.63
19,638.95
18,465.39
12,940.75
6,341.57
5,058.85
6,472.2
7,628.42
6,718.93
9,050.21
13,114.25
14,682.56
10,401.06
7,028.66
7,088.33
6,952.18
7,301.41
Book Value per Share
30,846.88
15,409.04
17,231.52
7,289.42
3,098.92
1,866.49
5,586.3
5,887.62
5,978.95
8,539.79
13,098.79
13,104.84
6,672.3
5,089.25
6,530.87
5,783.92
2,635.3
Tangible Book Value per Share
1
1
1
- -
1
1
2
2
3
3
5
7
8
11
15
17
17
Basic Weighted Avg Shares
29,404
34,386
22,315
12,466
11,762
11,451
8,312
35,586
33,588
56,155
6,621
18,613
19,098
17,257
20,208
32,822
39,948
Sales/Revenue/Turnover
-9.86
-16.55
-15.02
-37.94
-51.58
-65.51
-57.53
-8.75
-18.9
-0.15
-20.31
-9.59
-1.26
5.83
7.45
4.04
3.38
Operating Margin (%)
653
1,012
833
881
1,042
878
716
783
692
284
151
1,513
1,962
4,735
3,007
3,303
3,019
Depreciation Expense
-2,738
-12,528
-6,406
-4,563
-8,846
-7,594
-8,621
-2,909
-12,042
-4,803
11,252
7,740
-49,555
-14,540
8,497
498
-1,594
Net Income, GAAP
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
4.99
- -
- -
- -
- -
- -
- -
Effective Tax Rate (%)
-9.31
-36.43
-28.71
-36.6
-75.21
-66.32
-103.71
-8.17
-35.85
-8.55
169.95
41.58
-259.47
-84.26
42.05
1.52
-3.99
Profit Margin (%)
2,012
6,246
14,245
3,976
-477
-379
3,917
8,993
11,766
12,388
-24,368
29,152
25,024
37,309
38,614
-22,760
-52,880
Working Capital
28,527
- -
- -
- -
- -
- -
- -
- -
- -
155
430
175
10,552
214
28,222
23,035
1,925
LT Debt
22,352
16,554
22,404
16,044
8,315
6,185
13,436
18,709
18,511
35,935
76,126
119,400
129,580
137,704
116,798
120,981
137,678
Total Equity
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
-1.94
- -
- -
- -
1.03
- -
- -
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
18.08
- -
- -
- -
6.68
- -
- -
Return on Capital (%)
-11.87
-64.4
-32.89
-23.95
-74.13
-105.83
-87.87
-18.2
-65.25
-17.72
20.41
7.99
-47.76
-15.43
7.83
0.42
-1.29
Return on Common Equity (%)

Capital Structure

KRW

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
36,288
52,349
72,042
LT Borrowings
22,980
- -
1,272
LT Finance Leases
55
44
653
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
17
17
17
Market Capitalization
52,391
40,367
20,665

Working Capital

KRW

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
29,132
20,585
49,248
Cash, Cash Equivalents & STI
1,820
2,781
11,240
Accounts Receivable, Net
11,880
11,844
30,179
Inventories
1,007
1,081
113
Total Current Liabilities
51,892
64,891
102,128
Payables & Accruals
- -
- -
- -
ST Debt
36,288
52,349
72,042
Deferred Revenue
- -
- -
- -

Growth Rates

KRW

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
42.14%
12.01%
3.58%
Free Cash Flow
12.25%
-4.3%
-411.8%
Net Income, GAAP
-122.78%
-218.94%
-94.14%
Sales/Revenue/Turnover
52.77%
50.72%
62.42%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

KRW

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
4,886
4,867
4,858
5,596
20,208
2025
5,994
5,762
10,752
10,315
32,822
2026
10,120
8,761
- -
- -
- -

Quarterly Earnings Per Share

KRW

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
953.02
-120
30
-187.49
570
2025
-0.49
1,700
75.06
-216.52
30
2026
24.29
23
- -
- -
- -

Quarterly Dividends Per Share

KRW

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
Similar Companies
DataMeds AI, Inc. (NASDAQ:MEDS)
Selcuk Ecza Deposu Ticaret ve Sanayi A.S. (BIST:SELEC)
McKesson Corporation (NYSE:MCK)
Ibnsina Pharma (EGX:ISPH)
Cardinal Health, Inc. (NYSE:CAH)
Entero Healthcare Solutions Limited (NSE:ENTERO)
Business
Metacare Co., Ltd. (118000.KS) distributes pharmaceuticals and medical devices primarily in South Korea. The company wholesales and distributes orthopedic medical devices and consumables, including prodisc, hemostatic matrix, coolive tab, and artificial joints; provides pharmaceutical integration services and professional logistics; and engages in investment advisory and management consulting. It operates through four segments: pharmaceuticals distribution, medical devices and supplies, investment, and real estate services involving leasing and management of non-residential buildings. Founded in 2009 and headquartered in Hwaseong-si, South Korea, Metacare serves the healthcare sector, targeting hospitals, clinics, and related institutions with medical equipment, appliances, health products, and pharmaceuticals. In August 2024, the company changed its name from SMeDi Co., Ltd. to Metacare Co., Ltd., reflecting a strategic rebranding amid its focus on medical distribution and related services; it employs 22 to 32 staff and maintains operations centered in South Korea.